Business Context and Reporting Period
A SPAC III Acquisition Corp. (the "Company") is a blank check company incorporated in the British Virgin Islands, formed to effect a merger or business combination with one or more businesses, specifically targeting the Environmental, Sustainability, and Governance (ESG) and material technology sectors. This Form 10-Q covers the quarter ended March 31, 2025. The Company consummated its Initial Public Offering (IPO) in November 2024 and has not yet commenced operations or generated operating revenue.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Net Income | $413,202 | $0 |
| Interest Income (Trust Account) | $647,080 | $0 |
| General & Administrative Expenses | $233,878 | $0 |
| Cash and Cash Equivalents | $1,119,610 | $0 |
| Investments Held in Trust Account | $60,988,996 | $0 |
| Total Assets | $62,249,731 | $0 |
| Working Capital | $982,030 | N/A |
| Debt (Promissory Note) | $0 | $0 |
Note: Q1 2024 data reflects the pre-IPO period where the Company had no operations or cash balances.
Material Changes vs. Prior Period
- Revenue and Profit: The Company reported a net income of $413,202 for Q1 2025, driven entirely by interest income of $647,080 earned on the Trust Account, offset by $233,878 in general and administrative expenses. This contrasts with Q1 2024, where the Company had no operations and no net income.
- Liquidity: Cash held outside the Trust Account decreased from $1,598,890 at December 31, 2024, to $1,119,610 at March 31, 2025, primarily due to operating expenses and the repayment of a related-party promissory note.
- Debt Repayment: The Company fully repaid a $276,221 promissory note to its Sponsor on January 24, 2025. As of March 31, 2025, there is no outstanding debt.
- Trust Account Growth: Investments in the Trust Account increased by approximately $632,000 due to interest earnings, bringing the total to nearly $61 million.
Outlook, Risks, and Contingencies
- Business Combination Targets: The Company has entered into non-binding agreements with two potential targets:
- HD Group: A comprehensive service platform for students (China-based). Proposed consideration: $300 million in stock.
- Bioserica International Limited: A developer of bio-based antimicrobial materials. Proposed consideration: $200 million in stock.
- Going Concern: Management has identified substantial doubt about the Company's ability to continue as a going concern if a Business Combination is not completed by November 12, 2025 (or up to 18 months with extensions). The Company may need to liquidate if a combination is not consummated.
- Liquidity Needs: The Company relies on funds held outside the Trust Account for working capital. If insufficient, the Sponsor or affiliates may provide "Working Capital Loans" (up to $1.15 million convertible to units), though no such loans were outstanding as of March 31, 2025.
- Extension Mechanics: To extend the combination period beyond 12 months, the Sponsor must deposit $550,000 per three-month extension into the Trust Account.
Investor Verification Checklist
- Verify the status of the non-binding agreements with HD Group and Bioserica to determine if definitive agreements have been executed.
- Monitor the Company's cash burn rate outside the Trust Account to assess the need for additional Working Capital Loans from the Sponsor.
- Confirm the timeline for the mandatory liquidation date (November 12, 2025) and any potential extension filings.
- Review the redemption rights of public shareholders and the Sponsor's waiver of redemption rights for Founder Shares and Private Placement Units.
- Check for any updates on the "Representative Shares" issued to the underwriter (Maxim Group LLC) and their lock-up status.